Dingemans P - Search Results

1

Sexual dysfunction and hormonal changes in first episode psychosis patients on olanzapine or risperidone.

van Bruggen M, van Amelsvoort T, Wouters L, Dingemans P, de Haan L, Linszen D. van Bruggen M, et al. Among authors: dingemans p. Psychoneuroendocrinology. 2009 Aug;34(7):989-95. doi: 10.1016/j.psyneuen.2009.01.013. Epub 2009 Mar 4. Psychoneuroendocrinology. 2009. PMID: 19264412

2

Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders.

de Haan L, Beuk N, Hoogenboom B, Dingemans P, Linszen D. de Haan L, et al. Among authors: dingemans p. J Clin Psychiatry. 2002 Feb;63(2):104-7. doi: 10.4088/jcp.v63n0203. J Clin Psychiatry. 2002. PMID: 11874209 Clinical Trial.

3

Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.

Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, Spiering M, Schmitz N, Linszen DH. Korver N, et al. Aust N Z J Psychiatry. 2010 Mar;44(3):230-6. doi: 10.3109/00048670903487118. Aust N Z J Psychiatry. 2010. PMID: 20180725

4

Attitudes of patients toward the first psychotic episode and the start of treatment.

de Haan L, Peters B, Dingemans P, Wouters L, Linszen D. de Haan L, et al. Among authors: dingemans p. Schizophr Bull. 2002;28(3):431-42. doi: 10.1093/oxfordjournals.schbul.a006951. Schizophr Bull. 2002. PMID: 12645675

5

Subjective effects of cannabis before the first psychotic episode.

Peters BD, de Koning P, Dingemans P, Becker H, Linszen DH, de Haan L. Peters BD, et al. Among authors: dingemans p. Aust N Z J Psychiatry. 2009 Dec;43(12):1155-62. doi: 10.3109/00048670903179095. Aust N Z J Psychiatry. 2009. PMID: 20001415

6

Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up.

de Haan L, van Amelsvoort T, Dingemans P, Linszen D. de Haan L, et al. Among authors: dingemans p. Pharmacopsychiatry. 2007 Nov;40(6):264-8. doi: 10.1055/s-2007-992141. Pharmacopsychiatry. 2007. PMID: 18030650

7

Improvement of subjective well-being and enduring symptomatic remission, a 5-year follow-up of first episode schizophrenia.

de Haan L, Nimwegen Lv, Amelsvoort Tv, Dingemans P, Linszen D. de Haan L, et al. Among authors: dingemans p. Pharmacopsychiatry. 2008 Jul;41(4):125-8. doi: 10.1055/s-2008-1076729. Pharmacopsychiatry. 2008. PMID: 18651339

8

White-matter markers for psychosis in a prospective ultra-high-risk cohort.

Bloemen OJ, de Koning MB, Schmitz N, Nieman DH, Becker HE, de Haan L, Dingemans P, Linszen DH, van Amelsvoort TA. Bloemen OJ, et al. Among authors: dingemans p. Psychol Med. 2010 Aug;40(8):1297-304. doi: 10.1017/S0033291709991711. Epub 2009 Nov 9. Psychol Med. 2010. PMID: 19895720

9

Antisaccade task performance in patients at ultra high risk for developing psychosis.

Nieman D, Becker H, van de Fliert R, Plat N, Bour L, Koelman H, Klaassen M, Dingemans P, Niessen M, Linszen D. Nieman D, et al. Among authors: dingemans p. Schizophr Res. 2007 Sep;95(1-3):54-60. doi: 10.1016/j.schres.2007.06.022. Epub 2007 Jul 26. Schizophr Res. 2007. PMID: 17656071

10

Sustained specialized and family treatment in first-episode schizophrenia or related disorders: a 5-year randomized controlled trial.

de Haan L, Linszen D, Wouters L, Zwinderman K, Dingemans P. de Haan L, et al. Among authors: dingemans p. Psychol Med. 2023 Jul;53(10):4316-4323. doi: 10.1017/S003329172200099X. Epub 2022 Jun 8. Psychol Med. 2023. PMID: 35672956 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters